Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy

Details for Australian Patent Application No. 2011201761 (hide)

Owner McGill University Bionomics Limited

Inventors Rouleau, Guy; Lafreniere, Ronald; Rochefort, Daniel; Cossette, Patrick; Ragsdale, David; Berkovic, Samuel Frank

Agent Griffith Hack

Pub. Number AU-A-2011201761

Parent 2007201991

Filing date 19 April 2011

Wipo publication date 12 May 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 37/00 (2006.01) Details not covered by any other group of this subclass

Event Publications

12 May 2011 Application Open to Public Inspection

  Published as AU-A-2011201761

12 May 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201762-System and method for implementation of glycemic control products

2011201760-Electronic Disabling Device